浙江大学联合拼多多共同设立1亿元病毒感染性疾病防控专项基金

2020-01-30 佚名 浙大发布

当日,基金会宣布成立基金管理委员会和专家委员会,负责基金后续管理以及资金使用。

1月29日,浙江大学宣布联合上海寻梦信息技术有限公司(拼多多)成立浙江大学病毒感染性疾病防控专项基金基金规模为1亿元人民币。当日,基金会宣布成立基金管理委员会和专家委员会,负责基金后续管理以及资金使用。

据了解,此次捐赠款项将专项用于支持病毒感染及呼吸道传染性疾病防治,特别是此次新型冠状病毒疫情支援保障和科学研究等,包括为疫情严重地区医院配置医用物资,奖励有突出贡献的医护人员,以及用于病毒感染及危重症医学防控研究等。

专项基金专家委员会由国家卫健委高级别专家、传染病诊治国家重点实验室主任李兰娟院士,国家卫健委高级别专家、中国疾控中心主任高福院士,浙江大学医学院刘志红院士和段树民院士,清华大学医学院董晨院士,浙大二院沈华浩,上海交大瑞金医院瞿介明,深圳呼吸疾病研究所陈荣昌,中日医院曹彬,复旦大学中山医院宋元林,上海交大第一人民医院张旻等十余位长期从事病毒、免疫和炎症研究以及感染性呼吸与危重症医学的一线教授医生组成。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1745691, encodeId=f98b1e4569182, content=<a href='/topic/show?id=73826552320' target=_blank style='color:#2F92EE;'>#浙江大学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65523, encryptionId=73826552320, topicName=浙江大学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c35635545425, createdName=一闲, createdTime=Fri Dec 18 08:12:00 CST 2020, time=2020-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1655477, encodeId=e53d16554e754, content=<a href='/topic/show?id=7c2853311ac' target=_blank style='color:#2F92EE;'>#感染性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53311, encryptionId=7c2853311ac, topicName=感染性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=583d24724321, createdName=charl1234575, createdTime=Sun Nov 01 16:12:00 CST 2020, time=2020-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1665849, encodeId=0588166584950, content=<a href='/topic/show?id=978d53318de' target=_blank style='color:#2F92EE;'>#感染性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53318, encryptionId=978d53318de, topicName=感染性疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97fa26021282, createdName=12498fa0m19暂无昵称, createdTime=Mon Sep 07 05:12:00 CST 2020, time=2020-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035376, encodeId=e71420353e68e, content=<a href='/topic/show?id=718fe07371e' target=_blank style='color:#2F92EE;'>#疾病防控#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70737, encryptionId=718fe07371e, topicName=疾病防控)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25e7304, createdName=snf701207, createdTime=Wed Aug 26 14:12:00 CST 2020, time=2020-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=378651, encodeId=18313e86512a, content=加油,抵抗病毒, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/13/297abc49521542fee373596e497d37fc.jpg, createdBy=db695226500, createdName=1478fa69m73暂无昵称, createdTime=Thu Jan 30 14:05:10 CST 2020, time=2020-01-30, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1745691, encodeId=f98b1e4569182, content=<a href='/topic/show?id=73826552320' target=_blank style='color:#2F92EE;'>#浙江大学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65523, encryptionId=73826552320, topicName=浙江大学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c35635545425, createdName=一闲, createdTime=Fri Dec 18 08:12:00 CST 2020, time=2020-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1655477, encodeId=e53d16554e754, content=<a href='/topic/show?id=7c2853311ac' target=_blank style='color:#2F92EE;'>#感染性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53311, encryptionId=7c2853311ac, topicName=感染性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=583d24724321, createdName=charl1234575, createdTime=Sun Nov 01 16:12:00 CST 2020, time=2020-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1665849, encodeId=0588166584950, content=<a href='/topic/show?id=978d53318de' target=_blank style='color:#2F92EE;'>#感染性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53318, encryptionId=978d53318de, topicName=感染性疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97fa26021282, createdName=12498fa0m19暂无昵称, createdTime=Mon Sep 07 05:12:00 CST 2020, time=2020-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035376, encodeId=e71420353e68e, content=<a href='/topic/show?id=718fe07371e' target=_blank style='color:#2F92EE;'>#疾病防控#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70737, encryptionId=718fe07371e, topicName=疾病防控)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25e7304, createdName=snf701207, createdTime=Wed Aug 26 14:12:00 CST 2020, time=2020-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=378651, encodeId=18313e86512a, content=加油,抵抗病毒, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/13/297abc49521542fee373596e497d37fc.jpg, createdBy=db695226500, createdName=1478fa69m73暂无昵称, createdTime=Thu Jan 30 14:05:10 CST 2020, time=2020-01-30, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1745691, encodeId=f98b1e4569182, content=<a href='/topic/show?id=73826552320' target=_blank style='color:#2F92EE;'>#浙江大学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65523, encryptionId=73826552320, topicName=浙江大学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c35635545425, createdName=一闲, createdTime=Fri Dec 18 08:12:00 CST 2020, time=2020-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1655477, encodeId=e53d16554e754, content=<a href='/topic/show?id=7c2853311ac' target=_blank style='color:#2F92EE;'>#感染性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53311, encryptionId=7c2853311ac, topicName=感染性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=583d24724321, createdName=charl1234575, createdTime=Sun Nov 01 16:12:00 CST 2020, time=2020-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1665849, encodeId=0588166584950, content=<a href='/topic/show?id=978d53318de' target=_blank style='color:#2F92EE;'>#感染性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53318, encryptionId=978d53318de, topicName=感染性疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97fa26021282, createdName=12498fa0m19暂无昵称, createdTime=Mon Sep 07 05:12:00 CST 2020, time=2020-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035376, encodeId=e71420353e68e, content=<a href='/topic/show?id=718fe07371e' target=_blank style='color:#2F92EE;'>#疾病防控#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70737, encryptionId=718fe07371e, topicName=疾病防控)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25e7304, createdName=snf701207, createdTime=Wed Aug 26 14:12:00 CST 2020, time=2020-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=378651, encodeId=18313e86512a, content=加油,抵抗病毒, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/13/297abc49521542fee373596e497d37fc.jpg, createdBy=db695226500, createdName=1478fa69m73暂无昵称, createdTime=Thu Jan 30 14:05:10 CST 2020, time=2020-01-30, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1745691, encodeId=f98b1e4569182, content=<a href='/topic/show?id=73826552320' target=_blank style='color:#2F92EE;'>#浙江大学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65523, encryptionId=73826552320, topicName=浙江大学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c35635545425, createdName=一闲, createdTime=Fri Dec 18 08:12:00 CST 2020, time=2020-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1655477, encodeId=e53d16554e754, content=<a href='/topic/show?id=7c2853311ac' target=_blank style='color:#2F92EE;'>#感染性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53311, encryptionId=7c2853311ac, topicName=感染性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=583d24724321, createdName=charl1234575, createdTime=Sun Nov 01 16:12:00 CST 2020, time=2020-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1665849, encodeId=0588166584950, content=<a href='/topic/show?id=978d53318de' target=_blank style='color:#2F92EE;'>#感染性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53318, encryptionId=978d53318de, topicName=感染性疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97fa26021282, createdName=12498fa0m19暂无昵称, createdTime=Mon Sep 07 05:12:00 CST 2020, time=2020-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035376, encodeId=e71420353e68e, content=<a href='/topic/show?id=718fe07371e' target=_blank style='color:#2F92EE;'>#疾病防控#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70737, encryptionId=718fe07371e, topicName=疾病防控)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25e7304, createdName=snf701207, createdTime=Wed Aug 26 14:12:00 CST 2020, time=2020-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=378651, encodeId=18313e86512a, content=加油,抵抗病毒, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/13/297abc49521542fee373596e497d37fc.jpg, createdBy=db695226500, createdName=1478fa69m73暂无昵称, createdTime=Thu Jan 30 14:05:10 CST 2020, time=2020-01-30, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1745691, encodeId=f98b1e4569182, content=<a href='/topic/show?id=73826552320' target=_blank style='color:#2F92EE;'>#浙江大学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65523, encryptionId=73826552320, topicName=浙江大学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c35635545425, createdName=一闲, createdTime=Fri Dec 18 08:12:00 CST 2020, time=2020-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1655477, encodeId=e53d16554e754, content=<a href='/topic/show?id=7c2853311ac' target=_blank style='color:#2F92EE;'>#感染性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53311, encryptionId=7c2853311ac, topicName=感染性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=583d24724321, createdName=charl1234575, createdTime=Sun Nov 01 16:12:00 CST 2020, time=2020-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1665849, encodeId=0588166584950, content=<a href='/topic/show?id=978d53318de' target=_blank style='color:#2F92EE;'>#感染性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53318, encryptionId=978d53318de, topicName=感染性疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97fa26021282, createdName=12498fa0m19暂无昵称, createdTime=Mon Sep 07 05:12:00 CST 2020, time=2020-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035376, encodeId=e71420353e68e, content=<a href='/topic/show?id=718fe07371e' target=_blank style='color:#2F92EE;'>#疾病防控#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70737, encryptionId=718fe07371e, topicName=疾病防控)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25e7304, createdName=snf701207, createdTime=Wed Aug 26 14:12:00 CST 2020, time=2020-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=378651, encodeId=18313e86512a, content=加油,抵抗病毒, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/13/297abc49521542fee373596e497d37fc.jpg, createdBy=db695226500, createdName=1478fa69m73暂无昵称, createdTime=Thu Jan 30 14:05:10 CST 2020, time=2020-01-30, status=1, ipAttribution=)]
    2020-01-30 1478fa69m73暂无昵称

    加油,抵抗病毒

    0

相关资讯

关乎每个人的疾病防控 2018年北京要干些啥

2018年北京疾病预防控制工作全貌,一起了解下?

卫生防疫|洪涝灾害后重点疾病防控要点

洪涝灾害发生后,由于饮水饮食卫生状况恶化、环境污染、病媒生物孳生、人群接触机会增加及抵抗力下降等因素影响,容易发生各种传染病特别是肠道传染病、虫媒和自然疫源性传染病、经密切接触的传染病等的增加,做好这些疾病的防控工作十分重要。  肠道传染病是病原体经口侵入肠道并引起腹泻和/或其他脏器及全身性感染的一类疾病。灾区常见肠道传染病主要有细菌性痢疾、霍乱、伤寒和副伤寒、其他如沙门菌、副溶血性弧菌、空肠